Viewing Study NCT00982735


Ignite Creation Date: 2025-12-24 @ 10:17 PM
Ignite Modification Date: 2025-12-28 @ 11:55 PM
Study NCT ID: NCT00982735
Status: COMPLETED
Last Update Posted: 2014-04-16
First Post: 2009-09-22
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: An Observational Cohort Study to Evaluate the Safety and Efficacy of Micardis Tablets Taken Once Daily at 40 mg/Day and 80 mg/Day in Hypertensive Patients Under Real Life Conditions in Usual Clinical Practice
Sponsor: Boehringer Ingelheim
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Outcomes Module Eligibility Module Contacts Locations Module Adverse Events Module Baseline Characteristics Module Participant Flow Module